K Last-Barney

Binding Site Elucidation of Hydantoin-Based Antagonists of LFA-1 Using Multidisciplinary Technologies:  Evidence for the Allosteric Inhibition of a Protein−Protein Interaction

K Last-Barney, Walter Davidson, Mario Cardozo et al. · Journal of the American Chemical Society · 2001 · 130 citations

Allosteric Inhibition, Drug Target, Immunocytochemical Technique +22

Synergistic and overlapping activities of tumor necrosis factor- <i>alpha</i> and IL-1.

K Last-Barney, Carol Homon, Ronald B. Faanes et al. · The Journal of Immunology · 1988 · 101 citations · Full text

Expansion of cyclophosphamide-resistant cytotoxic precursors in vitro and in vivo by purified human interleukin 2.

V J Merluzzi, Karl Welte, Douglas M. Savage et al. · The Journal of Immunology · 1983 · 59 citations

Inflammation, Cytokine, Cyclophosphamide-resistant Cytotoxic Precursors +15

Small molecule LFA-1 antagonists compete with an anti-LFA-1 monoclonal antibody for binding to the CD11a I domain: development of a flow-cytometry-based receptor occupancy assay

Joseph R. Woska, K Last-Barney, Robert Rothlein et al. · Journal of Immunological Methods · 2003 · 23 citations

Medicine, Immunology, Autoimmunity +9

Similarities and distinctions between murine natural killer cells and lymphokine-activated killer cells

Vincent J. Merluzzzi, Mark D. Smith, K Last-Barney · Cellular Immunology · 1986 · 20 citations

Autoimmune Disease, Immune Regulation, Immunology +8